BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 56 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,502,094 | +30.0% | 114,996 | +35.0% | 0.00% | +100.0% |
Q2 2023 | $3,462,650 | -0.8% | 85,203 | +2.2% | 0.00% | 0.0% |
Q1 2023 | $3,490,078 | +23.0% | 83,375 | +28.0% | 0.00% | 0.0% |
Q4 2022 | $2,838,234 | -55.2% | 65,127 | -60.1% | 0.00% | -66.7% |
Q3 2022 | $6,337,000 | -6.5% | 163,241 | +2.1% | 0.00% | 0.0% |
Q2 2022 | $6,778,000 | +16.6% | 159,864 | +25.2% | 0.00% | +50.0% |
Q1 2022 | $5,813,000 | +9.5% | 127,702 | +16.7% | 0.00% | 0.0% |
Q4 2021 | $5,307,000 | +2.9% | 109,414 | +1.1% | 0.00% | 0.0% |
Q3 2021 | $5,158,000 | +0.3% | 108,253 | +2.1% | 0.00% | 0.0% |
Q2 2021 | $5,141,000 | +7.3% | 105,986 | +2.3% | 0.00% | 0.0% |
Q1 2021 | $4,791,000 | -2.7% | 103,582 | +0.1% | 0.00% | 0.0% |
Q4 2020 | $4,923,000 | +12.3% | 103,447 | +1.1% | 0.00% | 0.0% |
Q3 2020 | $4,385,000 | +17.0% | 102,318 | +11.3% | 0.00% | 0.0% |
Q2 2020 | $3,748,000 | +31.5% | 91,903 | +16.2% | 0.00% | +100.0% |
Q1 2020 | $2,850,000 | +32.4% | 79,070 | +56.1% | 0.00% | 0.0% |
Q4 2019 | $2,153,000 | +12.4% | 50,651 | +1.1% | 0.00% | 0.0% |
Q3 2019 | $1,916,000 | +8.1% | 50,091 | +9.9% | 0.00% | 0.0% |
Q2 2019 | $1,773,000 | -17.0% | 45,598 | -15.1% | 0.00% | 0.0% |
Q1 2019 | $2,136,000 | +13.4% | 53,685 | +3.9% | 0.00% | 0.0% |
Q4 2018 | $1,884,000 | +5.3% | 51,681 | +22.9% | 0.00% | 0.0% |
Q3 2018 | $1,789,000 | +13.4% | 42,065 | +2.9% | 0.00% | 0.0% |
Q2 2018 | $1,577,000 | +7.9% | 40,873 | -2.2% | 0.00% | 0.0% |
Q1 2018 | $1,462,000 | -15.2% | 41,777 | -11.6% | 0.00% | 0.0% |
Q4 2017 | $1,725,000 | +26.7% | 47,239 | +26.4% | 0.00% | 0.0% |
Q3 2017 | $1,362,000 | +1.3% | 37,363 | +1.9% | 0.00% | 0.0% |
Q2 2017 | $1,344,000 | +12.9% | 36,667 | +6.6% | 0.00% | 0.0% |
Q1 2017 | $1,190,000 | +30.2% | 34,409 | +19.5% | 0.00% | 0.0% |
Q4 2016 | $914,000 | +6.0% | 28,785 | +14.7% | 0.00% | 0.0% |
Q3 2016 | $862,000 | +14.3% | 25,086 | +18.6% | 0.00% | – |
Q2 2016 | $754,000 | +14.6% | 21,156 | +14.0% | 0.00% | – |
Q1 2016 | $658,000 | -10.8% | 18,552 | -1.0% | 0.00% | – |
Q4 2015 | $738,000 | -3.4% | 18,742 | -7.9% | 0.00% | -100.0% |
Q3 2015 | $764,000 | -0.1% | 20,346 | +13.8% | 0.00% | 0.0% |
Q2 2015 | $765,000 | -8.3% | 17,884 | -7.8% | 0.00% | 0.0% |
Q1 2015 | $834,000 | +5.2% | 19,394 | +4.4% | 0.00% | 0.0% |
Q4 2014 | $793,000 | – | 18,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ahrens Investment Partners LLC | 74,825 | $3,561,000 | 1.91% |
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 40,961 | $1,174,000 | 0.99% |
Diversified, LLC | 19,077 | $818,000 | 0.70% |
CORRADO ADVISORS, LLC | 9,645 | $459,000 | 0.35% |
Rikoon Group, LLC | 16,672 | $793,000 | 0.22% |
Eudaimonia Partners, LLC | 8,240 | $392,000 | 0.09% |
Arete Wealth Advisors, LLC | 10,658 | $507,000 | 0.07% |
SOA Wealth Advisors, LLC. | 4,900 | $242,000 | 0.07% |
Financial Advantage, Inc. | 833 | $39,000 | 0.04% |
Jacobi Capital Management LLC | 4,184 | $199,000 | 0.03% |